
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32665640</article-id><article-id pub-id-type="pmc">7360564</article-id><article-id pub-id-type="publisher-id">68308</article-id><article-id pub-id-type="doi">10.1038/s41598-020-68308-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Region-specific mechanisms of corticosteroid-mediated inotropy in rat cardiomyocytes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wacker</surname><given-names>Caroline</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Dams</surname><given-names>Niklas</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Schauer</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ritzer</surname><given-names>Anne</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Volk</surname><given-names>Tilmann</given-names></name><address><email>tilmann.volk@fau.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Wagner</surname><given-names>Michael</given-names></name><address><email>michael_wagner@tu-dresden.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 3311</institution-id><institution-id institution-id-type="GRID">grid.5330.5</institution-id><institution>Institut f&#x000fc;r Zellul&#x000e4;re und Molekulare Physiologie, </institution><institution>Friedrich-Alexander-Universit&#x000e4;t Erlangen-N&#x000fc;rnberg, </institution></institution-wrap>Waldstra&#x000df;e 6, 91054 Erlangen, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 3311</institution-id><institution-id institution-id-type="GRID">grid.5330.5</institution-id><institution>Muscle Research Center Erlangen (MURCE), </institution><institution>Friedrich-Alexander-Universit&#x000e4;t Erlangen-N&#x000fc;rnberg, </institution></institution-wrap>Erlangen, Germany </aff><aff id="Aff3"><label>3</label>Abteilung f&#x000fc;r Rhythmologie, Herzzentrum Dresden, Fetscherstra&#x000df;e 76, 01307 Dresden, Germany </aff></contrib-group><pub-date pub-type="epub"><day>14</day><month>7</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>14</day><month>7</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>10</volume><elocation-id>11604</elocation-id><history><date date-type="received"><day>21</day><month>2</month><year>2020</year></date><date date-type="accepted"><day>23</day><month>6</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Regional differences in ion channel activity in the heart control the sequence of repolarization and may contribute to differences in contraction. Corticosteroids such as aldosterone or corticosterone increase the L-type Ca<sup>2+</sup> current (I<sub>CaL</sub>) in the heart via the mineralocorticoid receptor (MR). Here, we investigate the differential impact of corticosteroid-mediated increase in I<sub>CaL</sub> on action potentials (AP), ion currents, intracellular Ca<sup>2+</sup> handling and contractility in endo- and epicardial myocytes of the rat left ventricle. Dexamethasone led to a similar increase in I<sub>CaL</sub> in endocardial and epicardial myocytes, while the K<sup>+</sup> currents I<sub>to</sub> and I<sub>K</sub> were unaffected. However, AP duration (APD) and AP-induced Ca<sup>2+</sup> influx (Q<sub>Ca</sub>) significantly increased exclusively in epicardial myocytes, thus abrogating the normal differences between the groups. Dexamethasone increased Ca<sup>2+</sup> transients, contractility and SERCA activity in both regions, the latter possibly due to a decrease in total phospholamban (PLB) and an increase PLBpThr17. These results suggest that corticosteroids are powerful modulators of I<sub>CaL</sub>, Ca<sup>2+</sup> transients and contractility in both endo- and epicardial myocytes, while APD and Q<sub>Ca</sub> are increased in epicardial myocytes only. This indicates that increased I<sub>CaL</sub> and SERCA activity rather than Q<sub>Ca</sub> are the primary drivers of contractility by adrenocorticoids.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Physiology</kwd><kwd>Cardiovascular biology</kwd><kwd>Circulation</kwd><kwd>Ion transport</kwd><kwd>Cardiovascular biology</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Aldosterone, a corticosteroid hormone of the adrenal gland and a key player in the renin&#x02013;angiotensin&#x02013;aldosterone cascade, has a pivotal role in maintaining total body Na<sup>+</sup> via its action on the mineralocorticoid receptor (MR) in epithelia that control excretion of NaCl such as the aldosterone sensitive distal nephron, the colon, or sweat ducts. Aldosterone thereby controls extracellular fluid volume and arterial blood pressure<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Beyond its action on Na<sup>+</sup>-absorbing epithelia, the effects of MR activation on various non-epithelial targets, such as the heart, are increasingly recognized. However, its mechanisms of action on these non-classical targets are far less understood. Clinical trials provide convincing evidence that MR antagonistic therapy increases survival in patients with heart failure, by, among others, decreasing the rate of fatal arrhythmias<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>, which are facilitated by electrical remodeling of the myocardium<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. In line with this observation, a number of studies have demonstrated that MR activation modulates ionic currents and transporters in ventricular cardiomyocytes, including the fast Na<sup>+</sup> current<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, the hyperpolarization-activated and cyclic-nucleotide gated current<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, the ryanodine receptor<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, and the L-type Ca<sup>2+</sup> current (I<sub>CaL</sub>)<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. The latter is of particular importance as alterations in I<sub>CaL</sub> not only affect cardiac electrophysiology and contractility directly, but also serve as a first step in chronic electrical and mechanical remodeling of the heart<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>. Consequently, mice overexpressing the MR show electrical abnormalities, arrhythmia and cardiac hypertrophy<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>.</p><p id="Par3">In the normal heart, repolarization is a well-coordinated process controlled by the sequence of excitation and regional differences in action potential duration (APD) among the ventricles. In fact, the regions excited early, such as endocardial or septal parts of the left ventricle, repolarize last due to longer action potentials (AP) and vice versa<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. Although differences in a number of ionic currents contribute to the heterogeneity in APD among the ventricle<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>, differences in the magnitude of the transient outward K<sup>+</sup> current (I<sub>to</sub>) between endo- and epicardial layers of the ventricle are the most prominent. In rodents such as mice and rats, these differences in I<sub>to</sub> are mainly responsible for the gradient in APD among the left ventricular free wall<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>, while in larger mammals such as dog or humans, I<sub>to</sub> magnitude exerts less influence on total APD, but rather controls the membrane voltage level during the early part of the plateau phase<sup><xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref></sup>. Since the AP constitutes the driving force for the ionic currents flowing during the AP, differences in AP waveform directly affect ion fluxes across the membrane. This is particularly important for the L-type Ca<sup>2+</sup> current, as the amount of Ca<sup>2+</sup> entering the myocytes during an AP controls excitation&#x02013;contraction&#x02013;coupling. For example, despite a similar I<sub>CaL</sub> magnitude in endo- and epicardial myocytes, the longer AP in endocardial myocytes leads to an increased AP-induced Ca<sup>2+</sup> influx<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Differences in duration and shape of the AP, therefore, not only control the sequence of repolarization but also affect Ca<sup>2+</sup> influx, intracellular Ca<sup>2+</sup> cycling, contractility and cardiac remodeling<sup><xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref></sup>. The particular relevance of the AP shape is highlighted by studies, in which epicardial myocytes displayed increases in Ca<sup>2+</sup> influx, Ca<sup>2+</sup> transients and contractility, when clamped on an endocardial AP and vice versa<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Moreover, alterations in AP waveform in ferret myocytes caused desynchronized SR Ca<sup>2+</sup> release which is typically observed in myocytes originating from failing hearts<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Although the magnitude of I<sub>to</sub> is the major parameter responsible for differences in AP shape and duration among different regions of the ventricular wall, it is important to note that the AP waveform of individual myocytes is a function of the cell&#x02019;s magnitude of both, I<sub>to</sub> and I<sub>CaL</sub>. In experiments, in which I<sub>to</sub>, I<sub>CaL</sub> and APD were measured in the same cells, Gomez and coworkers showed that early repolarization of the rat AP (APD<sub>20</sub>) neither correlated with the magnitude of I<sub>CaL</sub> nor with I<sub>to</sub> alone, but only with both currents together<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. This suggests that changes not only in the magnitude of I<sub>to</sub>, but also in I<sub>CaL</sub> might substantially affect AP waveform and in turn Ca<sup>2+</sup> influx, Ca<sup>2+</sup> transients and contractility.</p><p id="Par4">In the present study, we therefore hypothesized that the corticosteroid induced increase in I<sub>CaL</sub> affects AP shape, Ca<sup>2+</sup> influx, Ca<sup>2+</sup> transient and contractility differently in endo- and epicardial myocytes. To address this question, we investigated the influence of mineralocorticoid receptor activation on I<sub>CaL</sub>, AP-induced Ca<sup>2+</sup> influx, contractility, Ca<sup>2+</sup> transient and SR Ca<sup>2+</sup> handling in endo- and epicardial myocytes isolated from the rat left ventricle. We show that MR activation substantially increases contractility to a similar extent in both endo- and epicardial myocytes but modulates intracellular Ca<sup>2+</sup> handling differently.</p></sec><sec id="Sec2"><title>Results</title><p id="Par5">Incubation of isolated left ventricular cardiomyocytes for 24&#x000a0;h with corticosteroids, such as the mineralocorticoid aldosterone or the glucocorticoid corticosterone, has been shown to increase the L-type Ca<sup>2+</sup> current (I<sub>CaL</sub>) via activation of the mineralocorticoid receptor (MR)<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>. In the present study, we used dexamethasone as corticosteroid to stimulate I<sub>CaL</sub>. Moreover, in a previous study<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, insulin was part of the primary culture conditions and we later learned that it is a prerequisite for I<sub>CaL</sub> regulation by corticosteroids: Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A displays typical recordings of I<sub>CaL</sub> obtained from a control myocyte, a myocyte incubated with 1&#x000a0;&#x000b5;M dexamethasone, a myocyte incubated with 100&#x000a0;nM insulin and a myocyte incubated with the combination of both dexamethasone and insulin. 24&#x000a0;h incubation with dexamethasone substantially increased I<sub>CaL</sub> only in the presence of insulin. The current&#x02013;voltage (I&#x02013;V) relations shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B summarize similar experiments. On average, dexamethasone&#x02009;+&#x02009;insulin increased I<sub>CaL</sub> at 0&#x000a0;mV by 46% from 7.0&#x02009;&#x000b1;&#x02009;0.5 pApF<sup>&#x02212;1</sup> (n&#x02009;=&#x02009;21) to 10.2&#x02009;&#x000b1;&#x02009;0.8 pApF<sup>&#x02212;1</sup> (n&#x02009;=&#x02009;19, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01) while in the presence of dexamethasone (7.7&#x02009;&#x000b1;&#x02009;0.6 pApF<sup>&#x02212;1</sup>, n&#x02009;=&#x02009;19) or insulin (7.9&#x02009;&#x000b1;&#x02009;0.8 pApF<sup>&#x02212;1</sup>, n&#x02009;=&#x02009;15) alone, no significant difference was observed. For that reason we combined 1&#x000a0;&#x000b5;M dexamethasone with 100&#x000a0;nM insulin (DI) in all following experiments. To address the question whether DI increases I<sub>CaL</sub> via the MR or the glucocorticoid receptor (GR), we incubated myocytes with DI alone and with DI and the MR antagonist spironolactone (10&#x000a0;&#x000b5;M). 24&#x000a0;h incubation with DI substantially increased I<sub>CaL</sub>, while in the presence of spironolactone, I<sub>CaL</sub> remained at the level of the control myocytes (see Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A). The current&#x02013;voltage (I&#x02013;V) relations shown in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>B summarize similar experiments. Similar to the experiments shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, DI increased I<sub>CaL</sub> by 46% from 7.6&#x02009;&#x000b1;&#x02009;0.4 pApF<sup>&#x02212;1</sup> (n&#x02009;=&#x02009;21) to 11.1&#x02009;&#x000b1;&#x02009;0.6 pApF<sup>&#x02212;1</sup> (V<sub>Pip</sub>&#x02009;=&#x02009;0&#x000a0;mV, n&#x02009;=&#x02009;31, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001). In the presence of spironolactone, DI did not significantly affect I<sub>CaL</sub>, indicating that dexamethasone, like aldosterone or corticosterone<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, increases I<sub>CaL</sub> via the MR.<fig id="Fig1"><label>Figure 1</label><caption><p>Dexamethasone increases I<sub>CaL</sub> only in the presence of insulin. (<bold>A</bold>) Representative whole-cell current traces of I<sub>CaL</sub> recorded from myocytes incubated for 24&#x000a0;h under&#x000a0;control conditions (Control), with 1&#x000a0;&#x000b5;M dexamethasone, 100&#x000a0;nM insulin, 1&#x000a0;&#x000b5;M dexamethasone&#x02009;+&#x02009;100&#x000a0;nM insulin. Myocytes were clamped for 600&#x000a0;ms from the holding potential of V<sub>Pip</sub>&#x02009;=&#x02009;&#x02212;&#x02009;90&#x000a0;mV to test potentials between V<sub>Pip</sub>&#x02009;=&#x02009;&#x02212;&#x02009;60&#x000a0;mV up to&#x02009;+&#x02009;70&#x000a0;mV in steps of 10&#x000a0;mV. Na<sup>+</sup> currents were inactivated by a prepulse of 70&#x000a0;ms to &#x02212;&#x02009;50&#x000a0;mV. Basic cycle length was 3,000&#x000a0;ms. (<bold>B</bold>) Average current&#x02013;voltage relations of currents similar to those shown in A. I<sub>CaL</sub> was quantified by subtracting the peak current from the current at the end of the voltage pulse (at 600&#x000a0;ms). *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, dexamethasone&#x02009;+&#x02009;insulin versus control. 15&#x02009;&#x02264;&#x02009;n&#x02009;&#x02264;&#x02009;21.</p></caption><graphic xlink:href="41598_2020_68308_Fig1_HTML" id="MO1"/></fig>
<fig id="Fig2"><label>Figure 2</label><caption><p>The effect of dexamethasone is mediated by the mineralocorticoid receptor. (<bold>A</bold>) Representative whole-cell current traces of I<sub>CaL</sub> recorded from myocytes incubated for 24&#x000a0;h under&#x000a0;control conditions (Control), with 1&#x000a0;&#x000b5;M dexamethasone&#x02009;+&#x02009;100&#x000a0;nM insulin and 1&#x000a0;&#x000b5;M dexamethasone&#x02009;+&#x02009;100&#x000a0;nM insulin&#x02009;+&#x02009;10&#x000a0;&#x000b5;M spironolactone. Myocytes were clamped for 600&#x000a0;ms from the holding potential of V<sub>Pip</sub>&#x02009;=&#x02009;&#x02212;&#x02009;90&#x000a0;mV to test potentials between V<sub>Pip</sub>&#x02009;=&#x02009;&#x02212;&#x02009;60&#x000a0;mV up to&#x02009;+&#x02009;70&#x000a0;mV in steps of 10&#x000a0;mV. Basic cycle length was 3,000&#x000a0;ms. (<bold>B</bold>) Average current&#x02013;voltage relations of currents similar to those shown in (<bold>A</bold>). I<sub>CaL</sub> was quantified by subtracting the peak current from the current at the end of the voltage pulse (at 600&#x000a0;ms). *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, dexamethasone&#x02009;+&#x02009;insulin versus control; <sup>#</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, <sup>###</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 dexamethasone&#x02009;+&#x02009;insulin versus dexamethasone&#x02009;+&#x02009;insulin&#x02009;+&#x02009;spironolactone. 21&#x02009;&#x02264;&#x02009;n&#x02009;&#x02264;&#x02009;32.</p></caption><graphic xlink:href="41598_2020_68308_Fig2_HTML" id="MO2"/></fig>
</p><p id="Par6">To investigate regional differences in the effects of corticosteroids on I<sub>CaL</sub>, we isolated endo- and epicardial myocytes from the left ventricular free wall and investigated I<sub>CaL</sub> after 24&#x000a0;h incubation with DI. Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>A shows average I&#x02013;V relations of I<sub>CaL</sub> recorded from endo (left panel) and epicardial (right panel) myocytes. Compared to control, DI increased I<sub>CaL</sub> at 0&#x000a0;mV in endocardial and in epicardial myocytes to a similar extent by 45% (n&#x02009;=&#x02009;37, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) and 49% (n&#x02009;=&#x02009;36, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), respectively. We also investigated the effect of DI on repolarizing K<sup>+</sup> currents. The transient outward K<sup>+</sup> current (I<sub>to</sub>) displayed the typical gradient among the left ventricular free wall with much larger currents in epi-compared to endocardial myocytes. However, in both endo- and epicardial myocytes, I<sub>to</sub> magnitude was not affected by 24&#x000a0;h incubation with DI (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>B). To address a potential effect of DI on the delayed rectifier group of K<sup>+</sup> currents (I<sub>K</sub>), we used the current at the end of a 600&#x000a0;ms voltage pulse<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>C displays average I&#x02013;V relations obtained by plotting the current at the end of a 600&#x000a0;ms voltage pulse versus the pulse potential. We did neither observe regional differences nor an effect of DI on I<sub>K</sub>.<fig id="Fig3"><label>Figure 3</label><caption><p>Effect of DI treatment on I<sub>CaL</sub> and K<sup>+</sup> currents in endo- and epicardial myocytes. (<bold>A</bold>) Average current&#x02013;voltage relations of recordings similar to those shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig2" ref-type="fig">2</xref>, obtained from endo- and epicardial myocytes of the left ventricular free wall incubated for 24&#x000a0;h under control conditions (blue) and with DI (green). *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, DI versus control. (<bold>B</bold> and<bold> C</bold>) Average current&#x02013;voltage relations of I<sub>to</sub> and I<sub>K</sub> recorded from endo- and epicardial myocytes of the left ventricular free wall incubated for 24&#x000a0;h under control conditions (blue) and DI (green). Myocytes were clamped for 600&#x000a0;ms from the holding potential of V<sub>Pip</sub>&#x02009;=&#x02009;&#x02212;&#x02009;90&#x000a0;mV to test potentials between V<sub>Pip</sub>&#x02009;=&#x02009;&#x02009;+&#x02009;60&#x000a0;mV to &#x02212;&#x02009;80&#x000a0;mV in steps of &#x02212;20&#x000a0;mV. Basic cycle length was 3,000&#x000a0;ms. I<sub>to</sub> was quantified by subtracting the peak current from the current at the end of the voltage pulse (at 600&#x000a0;ms), I<sub>K</sub> was estimated as the current at the end of the voltage pulse (600&#x000a0;ms). ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, epi- versus endocardial myocytes incubated under control conditions, <sup>###</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, epi- versus endocardial myocytes incubated with DI.</p></caption><graphic xlink:href="41598_2020_68308_Fig3_HTML" id="MO3"/></fig>
</p><p id="Par7">Next, we recorded action potentials (AP) from endo- and epicardial myocytes. Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>A (upper panels) shows representative AP recordings obtained under control conditions (blue) and after 24&#x000a0;h incubation with DI (green). As reported previously, APs were much shorter in epicardial than in endocardial myocytes. DI substantially increased APD in epicardial but not in endocardial myocytes. On average, in epicardial myocytes APD at 90% repolarization (APD<sub>90</sub>) increased from 90.2&#x02009;&#x000b1;&#x02009;11.4 to 220.2&#x02009;&#x000b1;&#x02009;31.4&#x000a0;ms (24&#x02009;&#x02264;&#x02009;n&#x02009;&#x02264;&#x02009;28, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>C). In endocardial myocytes, the small increase in APD<sub>90</sub> did not reach statistical significance. Similar results were observed with respect to the APD at 0&#x000a0;mV (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>B). The substantial increase in epicardial APD in the absence of alterations in endocardial APD completely abolished the large difference in APD between endo- and epicardial myocytes in the presence of DI.<fig id="Fig4"><label>Figure 4</label><caption><p>DI treatment abrogates the gradient in APD. (<bold> A</bold>) Representative APs and corresponding AP-induced Ca<sup>2+</sup> currents recorded from endo- and epicardial myocytes incubated for 24&#x000a0;h under control conditions (blue) and with DI&#x000a0;(green). APs were elicited by a train of suprathreshold depolarizing current injections at a basic cycle length of 1,000&#x000a0;ms. (<bold>B</bold>) Average APD at repolarization to 0&#x000a0;mV (APD<sub>0mV</sub>). (<bold>C</bold>) Average APD at 90% repolarization (APD<sub>90</sub>). (<bold>D</bold>) Average peak Ca<sup>2+</sup> influx (I<sub>Peak</sub>) and (<bold>E</bold>) average total AP-induced Ca<sup>2+</sup> influx (Q<sub>Ca</sub>) obtained from similar recordings to those shown in (<bold> A</bold>). Numbers in bars indicate number of myocytes in each group.</p></caption><graphic xlink:href="41598_2020_68308_Fig4_HTML" id="MO4"/></fig>
</p><p id="Par8">Since under physiological conditions the &#x02018;command potential&#x02019; for the I<sub>CaL</sub> current is not a rectangular voltage pulse such the ones used in Figs.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, <xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref>, but rather the myocyte&#x02019;s own AP, we conducted AP-clamp experiments to address the question whether the DI-induced changes in AP shape and duration affect the AP induced Ca<sup>2+</sup> influx. We therefore recorded APs from myocytes and subsequently used their own individual AP as voltage template for the following voltage clamp experiments, in which we clamped the membrane voltage of each myocyte on its own AP in the absence and in the presence of 100&#x000a0;&#x000b5;M Cd<sup>2+</sup> to inhibit I<sub>CaL</sub>. The resulting current is a good estimate of the AP-induced Ca<sup>2+</sup> current<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>A (lower panels) displays the corresponding AP-induced Ca<sup>2+</sup> currents obtained from individual myocytes of endo- and epicardial origin recorded under control conditions (blue) and after incubation with DI (green). Incubation with DI increased the peak AP-induced Ca<sup>2+</sup> current in endo- and epicardial myocytes to a similar extent (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>D), reflecting the increase in I<sub>CaL</sub> shown in Figs.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, <xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref>. The area under the AP-induced Ca<sup>2+</sup> current equals the Ca<sup>2+</sup> charge (Q<sub>Ca</sub>), i.e. the total amount of Ca<sup>2+</sup>, entering the myocyte via L-type channels during an AP. As we have published previously<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, the long endocardial AP leads to a significantly larger Q<sub>Ca</sub> in endo-compared to epicardial myocytes under control conditions. Incubation with DI dramatically increased Q<sub>Ca</sub> by 301% (n&#x02009;=&#x02009;18 vs. n&#x02009;=&#x02009;20, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) in epicardial myocytes, while in endocardial myocytes the increase was much smaller (84%, n&#x02009;=&#x02009;19 vs. n&#x02009;=&#x02009;20, n.s.) and did not reach statistical significance (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>C,E).</p><p id="Par9">Given the substantial increase in AP-induced Ca<sup>2+</sup> influx, we combined Ca<sup>2+</sup> imaging with simultaneous sarcomere length measurements to investigate intracellular Ca<sup>2+</sup> transients and myocyte contractility. Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>A shows representative recordings of individual Ca<sup>2+</sup> transients (given as relative Fura ratio) obtained from an endo- and an epicardial myocyte under control conditions (blue) and after 24&#x000a0;h incubation with DI (green), while Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>B shows representative simultaneous recordings of sarcomere length. Despite the longer APD and the larger Q<sub>Ca</sub> in endocardial cardiomyocytes, the amplitude of Ca<sup>2+</sup> transients (endo: 0.20&#x02009;&#x000b1;&#x02009;0.01, n&#x02009;=&#x02009;48; epi: 0.23&#x02009;&#x000b1;&#x02009;0.02, n&#x02009;=&#x02009;52, n.s.) as well as fractional unloaded sarcomere shortening (endo: 5.0&#x02009;&#x000b1;&#x02009;0.5%, n&#x02009;=&#x02009;48; epi: 5.1&#x02009;&#x000b1;&#x02009;0.5%, n&#x02009;=&#x02009;52, n.s.) were similar in endocardial and epicardial myocytes after 24&#x000a0;h of incubation under control conditions (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>C+D). Similarly, diastolic Ca<sup>2+</sup> level and diastolic sarcomere length were not significantly different between endo- and epicardial myocytes under control conditions (see Table <xref rid="Tab1" ref-type="table">1</xref>). After 24&#x000a0;h incubation with DI, a substantial increase in the systolic Ca<sup>2+</sup> transient was observed in endo- (+&#x02009;70%, 0.34&#x02009;&#x000b1;&#x02009;0.02, n&#x02009;=&#x02009;48, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 vs. control) as well as in epicardial cardiomyocytes (+&#x02009;43%, 0.33&#x02009;&#x000b1;&#x02009;0.02, n&#x02009;=&#x02009;52, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 vs. control). Accordingly, unloaded fractional shortening increased by 74% (8.7&#x02009;&#x000b1;&#x02009;0.7%, n&#x02009;=&#x02009;48, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 vs. control) in endocardial cells and by 45% (7.4&#x02009;&#x000b1;&#x02009;0.5%, n&#x02009;=&#x02009;52, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 vs. control) in epicardial myocytes (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>C and D). Diastolic Ca<sup>2+</sup> levels and diastolic sarcomere length remained unaffected by DI (see Table <xref rid="Tab1" ref-type="table">1</xref>).<fig id="Fig5"><label>Figure 5</label><caption><p>Effect of DI treatment on Ca<sup>2+</sup> transients and contractility in endo- and epicardial myocytes.&#x000a0;(<bold>A</bold>) Representative Ca<sup>2+</sup> transient after 24&#x000a0;h incubation under control conditions (blue curve) and with DI (green curve). (<bold>B</bold>) Representative sarcomere length recordings of the same myocytes shown in<bold> A. C</bold>, average systolic increase in Fura ratio of recordings similar to those shown in (<bold>A</bold>), (<bold>D</bold>) average fractional sarcomere shortening of recordings similar to those shown in<bold> A</bold>. Numbers in bars indicate number of myocytes in each group.</p></caption><graphic xlink:href="41598_2020_68308_Fig5_HTML" id="MO5"/></fig>
<fig id="Fig6"><label>Figure 6</label><caption><p>Effect of DI treatment on SR&#x000a0;Ca<sup>2+</sup> handling. (<bold>A</bold>) Representative caffeine-induced Ca<sup>2+</sup> transients after 24&#x000a0;h incubation under control conditions (blue curves) and with DI (green curves). Caffeine (10&#x000a0;mM) was applied after 60&#x000a0;s of pacing at 1&#x000a0;Hz to ensure equal SR loading. (<bold>B</bold>) Average increase in Fura ratio in response to caffeine application. (<bold>C</bold>) Average relative Ca<sup>2+</sup> release (Rel. Ca<sup>2+</sup>-release) calculated by dividing the increase in Fura ratio during regular pacing (1&#x000a0;Hz) by the increase in Fura ratio after application of caffeine. (<bold>D</bold>) Representative recording of Ca<sup>2+</sup> transients after application of 1&#x000a0;&#x000b5;M thapsigargin obtained from a myocyte incubated under control conditions. (<bold>E</bold>) Average difference of systolic increase in Fura ratio calculated by subtraction of&#x000a0;the systolic increase in Fura ratio after 5&#x000a0;min incubation with 1&#x000a0;&#x000b5;M thapsigargin from the systolic increase in Fura ratio before application of 1&#x000a0;&#x000b5;M thapsigargin. Numbers in bars indicate number of myocytes in each group.</p></caption><graphic xlink:href="41598_2020_68308_Fig6_HTML" id="MO6"/></fig>
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Effect of DI treatment on Ca<sup>2+</sup> transients and contractility in endo- and epicardial myocytes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Endo</th><th align="left">Epi</th><th align="left">Endo DI</th><th align="left">Epi DI</th></tr></thead><tbody><tr><td align="left">Diastolic&#x000a0;Fura ratio</td><td char="&#x000b1;" align="char">0.84&#x02009;&#x000b1;&#x02009;0.01</td><td char="&#x000b1;" align="char">0.82&#x02009;&#x000b1;&#x02009;0.01</td><td char="&#x000b1;" align="char">0.81&#x02009;&#x000b1;&#x02009;0.01</td><td char="&#x000b1;" align="char">0.84&#x02009;&#x000b1;&#x02009;0.01</td></tr><tr><td align="left">Systolic Fura ratio</td><td char="&#x000b1;" align="char">1.14&#x02009;&#x000b1;&#x02009;0.03</td><td char="&#x000b1;" align="char">1.06&#x02009;&#x000b1;&#x02009;0.03</td><td char="&#x000b1;" align="char">1.40&#x02009;&#x000b1;&#x02009;0.03***</td><td char="&#x000b1;" align="char">1.35&#x02009;&#x000b1;&#x02009;0.05***</td></tr><tr><td align="left">Diastolic SL (&#x000b5;m)</td><td char="&#x000b1;" align="char">1.56&#x02009;&#x000b1;&#x02009;0.02</td><td char="&#x000b1;" align="char">1.62&#x02009;&#x000b1;&#x02009;0.02</td><td char="&#x000b1;" align="char">1.53&#x02009;&#x000b1;&#x02009;0.02</td><td char="&#x000b1;" align="char">1.55&#x02009;&#x000b1;&#x02009;0.02</td></tr><tr><td align="left">Systolic SL (&#x000b5;m)</td><td char="&#x000b1;" align="char">1.47&#x02009;&#x000b1;&#x02009;0.02</td><td char="&#x000b1;" align="char">1.57&#x02009;&#x000b1;&#x02009;0.02</td><td char="&#x000b1;" align="char">1.38&#x02009;&#x000b1;&#x02009;0.02*</td><td char="&#x000b1;" align="char">1.43&#x02009;&#x000b1;&#x02009;0.02***</td></tr></tbody></table><table-wrap-foot><p>Diastolic and peak (Systolic) intracellular Ca<sup>2+</sup> concentration (given as Fura ratio) and recorded from endo- and epicardial myocytes after 24&#x000a0;h incubation under control conditions or with DI. Diastolic and peak (Systolic) sarcomere length (SL) recorded during the same experiments. *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, DI versus control. 30&#x02009;&#x02264;&#x02009;n&#x02009;&#x02264;&#x02009;36.</p></table-wrap-foot></table-wrap>
</p><p id="Par10">To examine whether the increase in Ca<sup>2+</sup> transient was due to an increased Ca<sup>2+</sup> content of the SR, we analyzed Ca<sup>2+</sup> transients evoked by rapid application of 10&#x000a0;mM caffeine after 60&#x000a0;s of steady-state pacing at 1&#x000a0;Hz. Figure&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>A displays typical caffeine-induced Ca<sup>2+</sup> transients recorded from endo- and epicardial myocytes under control conditions (blue) and after incubation with DI (green). Since caffeine locks the ryanodine-receptor in an open state, Ca<sup>2+</sup> release from the SR is maximal<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. Accordingly, the Ca<sup>2+</sup> transients were substantially larger than those observed in response to pacing. SR Ca<sup>2+</sup> content was assessed as the amplitude of the Ca<sup>2+</sup> transients and was similar in endo- and epicardial myocytes under control conditions. Interestingly, DI did not significantly alter SR Ca<sup>2+</sup> content (see Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>B). However, in the presence of DI, the amplitude of the Ca<sup>2+</sup> transients during regular pacing reached ~&#x02009;70% of the caffeine-induce Ca<sup>2+</sup> transients, while under control conditions Ca<sup>2+</sup> transients during pacing reached only&#x02009;~&#x02009;30% of the caffeine-induced Ca<sup>2+</sup> transients (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>C). This suggests that incubation with DI leads to a substantial increase in fractional release of Ca<sup>2+</sup> from the SR.</p><p id="Par11">To further address this question, we assessed Ca<sup>2+</sup> transients under steady-state pacing at 1&#x000a0;Hz and then blocked Ca<sup>2+</sup> uptake into the SR by inhibiting the SERCA using thapsigargin (1&#x000a0;&#x000b5;M) leaving residual Ca<sup>2+</sup> transients arising from Ca<sup>2+</sup> influx via L-type Ca<sup>2+</sup> channels only. Figure&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>D displays a typical recording of Ca<sup>2+</sup> transients stimulated by 1&#x000a0;Hz pacing. The arrow indicates the application of thapsigargin to the bath solution. Within 3&#x02013;5&#x000a0;min, Ca<sup>2+</sup> transients had decreased to a residual amplitude reflecting Ca<sup>2+</sup> influx from the extracellular space only. Figure&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>E summarizes similar experiments and displays the difference between the amplitude of Ca<sup>2+</sup> transients before and after the application of thapsigargin thus equaling the amount of Ca<sup>2+</sup> released from the SR. In both, endo- and epicardial myocytes, DI substantially increased SR Ca<sup>2+</sup> release. Since the total amount of Ca<sup>2+</sup> in the SR was not affected (see Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>B), this confirms that dexamethasone treatment increased the fractional release of Ca<sup>2+</sup> from the SR during each cardiac cycle.<fig id="Fig7"><label>Figure 7</label><caption><p>Effect of DI treatment on the time constants of cytosolic Ca<sup>2+</sup> removal pathways. (<bold>A</bold>) Average Ca<sup>2+</sup> transport time constants of SERCA&#x02009;+&#x02009;NCX (&#x003c4;<sub>SERCA&#x000a0;+&#x000a0;NCX</sub>) estimated by monoexponential fitting of the decay of the Ca<sup>2+</sup> transients recorded during regular pacing at 1&#x000a0;Hz. (<bold>B</bold>) Average Ca<sup>2+</sup> transport time constants of NCX (&#x003c4;<sub>NCX</sub>) obtained by monoexponential fitting of the decay of the Ca<sup>2+</sup> transients in response to caffeine application. (<bold>C</bold>) Average average Ca<sup>2+</sup> transport time constants of SERCA (&#x003c4;<sub>SERCA</sub>) calculated by subtracting the NCX-rate constant calculated from caffeine-induced Ca<sup>2+</sup> transients from the rate constants of the decay of Ca<sup>2+</sup> transient during regular pacing. Numbers in bars indicate number of myocytes in each group.</p></caption><graphic xlink:href="41598_2020_68308_Fig7_HTML" id="MO7"/></fig></p><p id="Par12">In light of increased Ca<sup>2+</sup> release from the SR and an increased Ca<sup>2+</sup> influx from the extracellular space, both Ca<sup>2+</sup> extrusion via the Na/Ca exchanger (NCX) and Ca<sup>2+</sup> reuptake into the SR via SERCA should be increased in myocytes treated with DI. We therefore assessed time and rate constants of the decline of Ca<sup>2+</sup> transients during regular pacing and in response to application of caffeine. In DI treated myocytes the time constant of the Ca<sup>2+</sup> transient decay was accelerated in both endo- and epicardial myocytes (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>) indicating increased rates of Ca<sup>2+</sup> removal from the cytoplasm. The time constant of the caffeine-induced Ca<sup>2+</sup> transient decay was much slower, since in the presence of caffeine, Ca<sup>2+</sup>extrusion from the myocytes via the NCX is the only significant pathway left. In myocytes incubated with DI, the NCX time constants were accelerated compared to control which is consistent with the increased AP-induced Ca<sup>2+</sup> influx upon DI treatment. The SERCA time constant (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>C, calculated as the reciprocal value of the difference in total and NCX-dependent rate-constants of the decay of the Ca<sup>2+</sup> transient) was also substantially accelerated by DI treatment.</p><p id="Par13">Finally, to address mechanisms underlying the increased SERCA transport rate, we performed western blot experiments in cardiomyocytes incubated for 24&#x000a0;h under control conditions and after treatment with DI to quantify SERCA and phospholamban expression as well as phospholamban phosphorylation. Since SERCA activity was similar in endo- and epicardial myocytes of both, control and DI groups, and in order to increase the total protein yield, we used isolated myocytes of the whole left ventricle for western blot experiments. Figure&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>A&#x02013;D display typical western blots stained against SERCA (8A), phospholamban (8B) and, using phospho-specific antibodies, against pSer16 (8C) and pThr17 (8D). Figure&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>E summarizes the results of similar western blots and shows that SERCA expression is unaffected by treatment with dexamethasone while phospholamban expression was decreased. Moreover, phosphorylation of phospholamban increased at the Thr17 site thereby further reducing the inhibitory action of phospholamban on SERCA. This is consistent with increased SERCA activity.<fig id="Fig8"><label>Figure 8</label><caption><p>Effect of DI treatment on SERCA and PLB protein expression and phosphorylation.&#x000a0;(<bold>A-D</bold>) Representative western blots stained for SERCA2 (<bold>A</bold>, 100&#x000a0;kDa), PLB (<bold>B</bold>, 25&#x000a0;kDa), phospho-PLB-Ser16 (<bold>C</bold>, 25&#x000a0;kDa) and phospho-PLB-Thr17 (<bold>D</bold>, 25&#x000a0;kDa). Protein was isolated from left ventricular myocytes incubated for 24&#x000a0;h under control conditions (Control) or with DI. Arrows indicate the according molecular weight level of the target protein. (<bold>E</bold>) Average relative protein expression was assessed by western blot quantification (normalization by Ponceau staining) of&#x000a0;control (blue) and DI treated myocytes (green). n&#x02009;=&#x02009;5 matched cell isolations. The full length gels of the western blots including the corresponding Ponceau stains are shown in the supplemental figure.</p></caption><graphic xlink:href="41598_2020_68308_Fig8_HTML" id="MO8"/></fig>
</p></sec><sec id="Sec3"><title>Discussion</title><p id="Par14">In the present study, MR activation increased I<sub>CaL</sub> to a similar extent in endo- and epicardial myocytes, demonstrating that, independent of regional origin, I<sub>CaL</sub> is not only similar in magnitude, but is also identically affected by MR agonists. Although treatment with DI led to a much larger increase in APD and AP-induced Ca<sup>2+</sup> influx in epicardial myocytes, the increase in intracellular Ca<sup>2+</sup> transient and, hence, contractility was similar in both regions. Moreover, SR Ca<sup>2+</sup> content was similar in both regions and not affected by DI treatment. We discovered that in both regions the fractional release of Ca<sup>2+</sup> from the SR was increased by DI treatment. Our results suggest that the increase in I<sub>CaL</sub> density rather than APD or AP-induced Ca<sup>2+</sup> influx controls the increase in Ca<sup>2+</sup> transient and contractility observed by DI treatment.</p><p id="Par15">In the present study, we confirm regional differences in AP shape and duration as well as in underlying ionic currents that we and others have previously described for the left ventricular free wall of the rat<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup>. Specifically, APD was substantially shorter in epicardial than in endocardial myocytes. This difference is attributable at least to a large extent to the larger epicardial I<sub>to</sub> current density, while other ionic currents, such as I<sub>K</sub> and I<sub>CaL</sub>, were similar in both regions. Since the AP waveform constitutes the voltage driving force for ionic currents including I<sub>CaL</sub>, the longer AP in endocardial myocytes led to an increased AP-induced Ca<sup>2+</sup> influx in endocardial compared to epicardial myocytes, despite of a similar current density of I<sub>CaL</sub> in both regions. This is in line with previous observations<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR30">30</xref></sup> and underlines the importance of AP shape for control of the AP-induced Ca<sup>2+</sup> influx. Moreover, all recordings in the present study were performed after at least 24&#x000a0;h incubation, hence, our data show that the regional differences in APD, underlying ionic currents and AP-induced Ca<sup>2+</sup> influx remain well preserved even after a prolonged (24&#x02013;36&#x000a0;h) period of primary culture.</p><p id="Par16">Despite the larger AP-induced Ca<sup>2+</sup> influx in endocardial myocytes, the intracellular Ca<sup>2+</sup> transient as well as unloaded sarcomere shortening were similar in myocytes obtained from both regions. This fits well to previous observations in canine<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref></sup> and rabbit<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> left ventricle, while in mouse left ventricle a larger Ca<sup>2+</sup> transient was found in endocardial myocytes<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>. For the rat left ventricle, conflicting results have been reported. Fowler et al. showed larger Ca<sup>2+</sup> transients in endocardial myocytes probably evoked by an increased SR Ca<sup>2+</sup> content<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. However, they did not address myocyte contractility. On the other hand, Cazorla et al. reported similar Ca<sup>2+</sup> transient amplitudes<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> and Smail et al. also reported similar Ca<sup>2+</sup> transient amplitudes and myocyte shortening in endo- and epicardial myocytes<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. We also found no significant difference in Ca<sup>2+</sup> transient amplitude or sarcomere shortening. Moreover, in our hands SR Ca<sup>2+</sup> content was similar in endo- and epicardial myocytes, suggesting that the larger AP-induced Ca<sup>2+</sup> influx in endocardial myocytes does not result in an increased SR Ca<sup>2+</sup> filling state. In a state of intracellular Ca<sup>2+</sup> homeostasis, a larger Ca<sup>2+</sup> influx from the extracellular space into the cytoplasm during each AP must be matched by an increased Ca<sup>2+</sup> extrusion into the extracellular space, carried predominantly by the NCX<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. Consistently, we found a trend towards a shorter time constant of NCX Ca<sup>2+</sup> removal in endocardial compared to epicardial myocytes (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>B), possibly indicating an increased NCX activity. This trend did not reach statistical significance, however, one should keep in mind that the difference in NCX time constant necessary to match the increased Ca<sup>2+</sup> influx in endocardial myocytes without an increase in Ca<sup>2+</sup> transient might be small and below our detection threshold, since the amount of Ca<sup>2+</sup> entering via L-type current and exiting via the NCX is only a&#x000a0;small fraction of&#x000a0;the total Ca<sup>2+</sup> transient. Moreover, by using EGTA in the pipette solution in our AP-clamp experiments we might have somewhat overestimated AP-induced Ca<sup>2+</sup> influx since EGTA moderately ameliorates<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> Ca<sup>2+</sup>-induced Ca<sup>2+</sup>-inactivation of I<sub>CaL</sub>.</p><p id="Par17">It is well established that MR activation for&#x02009;&#x0003e;&#x02009;18&#x02013;24&#x000a0;h increases I<sub>CaL</sub> in vitro in isolated cardiomyocytes<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup> as well as in vivo in mice with an increased plasma aldosterone concentration<sup><xref ref-type="bibr" rid="CR40">40</xref></sup> or in transgenic mice overexpressing the MR<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. In the present study, we demonstrate that MR activation increases I<sub>CaL</sub> in endo- and in epicardial myocytes to a&#x000a0;similar extent. Accordingly, regulation of I<sub>CaL</sub> magnitude by corticosteroids per se does not directly contribute to regional differences among the left ventricular free wall. However, especially in the early phase of the AP, the relation of the magnitudes of the repolarizing K<sup>+</sup>-current I<sub>to</sub> and the depolarizing I<sub>CaL</sub> not only sets the level of the plateau potential and controls early repolarization and the APD<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> but is also a potent modulator of the Ca<sup>2+</sup>-influx during the AP. For example, an acute delay in early repolarization (e.g. caused by a decrease in I<sub>to</sub>) increased AP-induced Ca<sup>2+</sup> influx<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR41">41</xref></sup>. One would therefore expect that an acute delay in early repolarization caused by an increase in I<sub>CaL</sub> should even further increase the AP-induced Ca<sup>2+</sup> influx, since not only the driving force (i.e. the membrane potential set by the AP) changes, but also the Ca<sup>2+</sup> conductance of the membrane. Indeed, the increase in I<sub>CaL</sub> we observed in response to MR activation substantially delayed early repolarization and increased APD, predominantly in epicardial myocytes, to such an extent that the endo-epicardial differences in APD disappeared. As a consequence, AP induced Ca<sup>2+</sup>-influx increased substantially in epicardial and to&#x000a0;a lesser (but not significant) extent in endocardial myocytes. The relatively small increase of the AP induced Ca<sup>2+</sup>-influx in endocardial myocytes is consistent with their per se longer AP and delayed early repolarization, which leaves less room for an increase in APD upon an increase in I<sub>CaL</sub>.</p><p id="Par18">MR activation led to a substantial increase in the intracellular Ca<sup>2+</sup> transient in both endo- and epicardial myocytes. A prolonged AP with a resulting increase in sarcolemmal Ca<sup>2+</sup> influx might alter several factors contributing to the intracellular Ca<sup>2+</sup> transient: an increase in Ca<sup>2+</sup> influx can trigger an increased release from the SR and might also increase the SR Ca<sup>2+</sup> content which in turn increases SR Ca<sup>2+</sup> release. Moreover, fractional release of Ca<sup>2+</sup> from the SR is controlled by two mechanisms, the SR Ca<sup>2+</sup> content and the magnitude of the trigger Ca<sup>2+</sup>, i.e. the AP-induced Ca<sup>2+</sup> influx<sup><xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>. In the present study, we found no increase in SR Ca<sup>2+</sup> content despite a substantial increase in AP-induced Ca<sup>2+</sup> influx and in SERCA activity. The increase in amplitude of the Ca<sup>2+</sup> transient can be explained by an increase in fractional release from the SR and (to a lesser extent) by an increase in trans-sarcolemmal Ca<sup>2+</sup> influx. This finding is supported by previous observations. Trafford et al. showed that an increase in Ca<sup>2+</sup> influx can substantially increase Ca<sup>2+</sup> release from the SR (and contractility) in the absence of effects on SR Ca<sup>2+</sup> content<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>. In animal models of heart failure with an increase&#x000a0;in APD, Sah<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> and Kaprielian<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> observed an increased Ca<sup>2+</sup> release from the SR in the absence of an increased SR Ca<sup>2+</sup> content. In our study, fractional Ca<sup>2+</sup> release averaged&#x02009;~&#x02009;40% under control conditions which is similar to the&#x02009;~&#x02009;50% observed by Picht et al<italic>.</italic><sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. In cardiomyocytes from mice overexpressing the MR or after 48&#x000a0;h of incubation with aldosterone, SR Ca<sup>2+</sup> content was also unaltered compared to control myocytes<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Since Bassani et al.<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> found only a 4% increase in SR Ca<sup>2+</sup> content in response to a switch to high loading condition, one could speculate that already under control conditions, SR Ca<sup>2+</sup> content might be nearly maximal. Moreover, Bode et al.<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> could show that in rat cardiomyocytes, SR Ca<sup>2+</sup> content only weakly depends on SERCA activity, when the SR Ca<sup>2+</sup> content is high. This was explained by an increase in SR Ca<sup>2+</sup> leak. Interestingly, aldosterone has been shown to increase SR Ca<sup>2+</sup> leak by downregulation of FKBP12 and 12.6 expression, thereby further limiting a potential increase in SR Ca<sup>2+</sup> load<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. SERCA activity is in addition modulated by SUMOylation<sup><xref ref-type="bibr" rid="CR48">48</xref>,<xref ref-type="bibr" rid="CR49">49</xref></sup>. SUMOylation of SERCA by SUMO1 is decreased in heart failure and contributes to decreased SERCA activity under this condition. Moreover, &#x003b2;-arrestin-2 enhances SERCA SUMOylation<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Interestingly, glucocorticoids decrease &#x003b2;-arrestin-2 expression at least in human lung adenocarcinoma cells<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>, could thus indirectly decrease SUMOylation of SERCA and thereby reduce SERCA activity. Taken together, modulation of I<sub>CaL</sub> density via the MR appears as a potent regulator of intracellular Ca<sup>2+</sup> transient magnitude and contractility in both, endo- and epicardial myocytes.</p></sec><sec id="Sec4"><title>Methods</title><sec id="Sec5"><title>Isolation of myocytes</title><p id="Par19">Cardiomyocytes were isolated from the left ventricular free wall of female Wistar rats (~&#x02009;220&#x000a0;g) as described previously<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. After induction of deep anesthesia by intraperitoneal injection of thiopental-sodium (100&#x000a0;mg&#x000a0;kg<sup>&#x02212;1</sup> body mass), the heart was quickly excised and placed into cold (4&#x000a0;&#x000b0;C) Tyrode&#x02019;s solution. Subsequently, the aorta was retrogradely perfused for 5&#x000a0;min with modified Tyrode&#x02019;s solution containing 4.5&#x000a0;mM Ca<sup>2+</sup> and 5&#x000a0;mM EGTA (~&#x02009;1&#x000a0;&#x003bc;M free Ca<sup>2+</sup> concentration) supplemented with 1&#x000a0;&#x003bc;M insulin (Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany). The perfusion was continued for 19&#x000a0;min, recirculating 25&#x000a0;ml of the same solution containing collagenase (CLS type II, 160 U/ml, Biochrom KG, Berlin, Germany) and protease (type XIV, 0.6 U/ml, Sigma). Then, the heart was perfused for another 5&#x000a0;min with storage solution<sup><xref ref-type="bibr" rid="CR8">8</xref></sup> containing 100&#x000a0;&#x003bc;M Ca<sup>2+</sup>. Using fine forceps, tissue portions of the subendocardial (endocardial) and subepicardial (epicardial) layers were taken and placed in separate cell culture dishes containing the same solution at 37&#x000a0;&#x000b0;C. Tissue pieces were minced and gently agitated to obtain single cardiomyocytes. Myocytes were stepwise adapted to physiological Ca<sup>2+</sup> levels, transferred to cell culture dishes containing storage solution supplemented with 1&#x000a0;g&#x000a0;l<sup>&#x02212;1</sup> BSA, 100&#x000a0;IU&#x000a0;ml<sup>&#x02212;1</sup> penicillin and 0.1&#x000a0;mg&#x000a0;ml<sup>&#x02212;1</sup> streptomycin and stored at 37&#x000a0;&#x000b0;C in a water-saturated atmosphere containing 5% CO<sub>2</sub>. For incubation with dexamethasone and insulin, appropriate amounts of stock solutions containing dexamethasone (dissolved in 100% ethanol) and insulin were added to the respective cell culture dishes; the corresponding amount of ethanol was added to control groups, the final concentration of ethanol was&#x02009;~&#x02009;0.02%. Isolated cardiomyocytes were used for experiments for up to 36&#x000a0;h. Only quiescent single rod-shaped cells with clear cross striations were used for experiments. All experiments were performed in accordance with relevant guidelines and regulations and all experimental protocols were approved by the <italic>Regierung von Mittelfranken</italic>, license No: 621&#x02013;2,531.32&#x02013;11/05.</p></sec><sec id="Sec6"><title>Patch-clamp technique</title><p id="Par20">The ruptured-patch whole-cell configuration was used as described previously<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup>. Myocardial cells were transferred into an elongated chamber (2.5&#x02009;&#x000d7;&#x02009;20&#x000a0;mm), mounted on the stage of an inverted microscope (Axiovert 25, Zeiss, Jena, Germany) and initially superfused with control solution. All experiments were performed at room temperature (22&#x02013;25&#x000a0;&#x000b0;C). Patch pipettes were pulled from borosilicate glass (GC150-15, Clark Electromedical Instruments, Reading, UK) using a P-97 Puller (Sutter Instruments, Novato, CA, USA). Pipette resistance (R<sub>Pip</sub>) was 1.5&#x02014;5 M&#x02126;. Currents were recorded using an EPC-10 amplifier (HEKA Elektronik, Lambrecht, Germany), controlled by PULSE-Software (HEKA Elektronik). Membrane voltage (V<sub>m</sub>) and APs were recorded in the zero current-clamp mode and ionic currents in the voltage-clamp mode. For AP voltage-clamp recordings, APs were recorded at the beginning of the experiments and used as a voltage template in the voltage-clamp mode of the amplifier<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR53">53</xref></sup>. Membrane capacitance (C<sub>m</sub>) and series resistance (R<sub>s</sub>) were calculated using the automated capacitance compensation procedure of the EPC-10 amplifier. Series resistance was in the range of&#x02009;~&#x02009;5 M&#x02126;, was not allowed to exceed 10 M&#x02126; and was compensated by 85%. The reference electrode of the amplifier headstage was bathed in pipette solution in a separate chamber and was connected to the bath solution via an agar&#x02013;agar bridge filled with pipette solution. Pipette potential (V<sub>Pip</sub>) and V<sub>m</sub> were corrected for liquid junction potentials at the bridge-bath junction. Whole-cell currents were low-pass filtered at 1&#x000a0;kHz and sampled at 5&#x000a0;kHz. Action potentials were sampled at 5&#x000a0;kHz.</p><p id="Par21">To assess I<sub>CaL</sub>, myocytes were clamped for 600&#x000a0;ms from the holding potential of &#x02212;&#x02009;90&#x000a0;mV to test potentials between &#x02212;&#x02009;60&#x000a0;mV and&#x02009;+&#x02009;70&#x000a0;mV in steps of 10&#x000a0;mV. Na<sup>+</sup> currents were inactivated by a prepulse of 70&#x000a0;ms to &#x02212;&#x02009;50&#x000a0;mV. Basic cycle length was 3,000&#x000a0;ms. I<sub>CaL</sub> was quantified by subtracting the current at the end of the test pulse from the peak current.<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> To elicit outward K<sup>+</sup> currents, myocytes were clamped for 600&#x000a0;ms from the holding potential of &#x02212;&#x02009;90&#x000a0;mV to test potentials between 60&#x000a0;mV and &#x02212;&#x02009;80&#x000a0;mV in steps of &#x02212;&#x02009;20&#x000a0;mV. Na<sup>+</sup> currents were inactivated by a prepulse of 20&#x000a0;ms to &#x02212;&#x02009;50&#x000a0;mV. Basic cycle length was 3,000&#x000a0;ms. I<sub>to</sub> was quantified by subtracting the current at the end of the test pulse from the peak current. I<sub>K</sub> was defined as the current at the end of the voltage pulse.</p></sec><sec id="Sec7"><title>Ca<sup>2+</sup> epifluorescence measurements</title><p id="Par22">Ca<sup>2+</sup> epifluorescence was recorded as previously described<sup><xref ref-type="bibr" rid="CR55">55</xref>,<xref ref-type="bibr" rid="CR56">56</xref></sup>. Cells were incubated in modified Tyrode&#x02019;s solution with Fura-2-AM (4&#x000a0;&#x003bc;mol/l). Cells were transferred into a chamber (self-manufactured) mounted on an inverted microscope (Nikon DM IRB, Nikon, D&#x000fc;sseldorf, Germany). Ca<sup>2+</sup> transients were recorded during field stimulation (1&#x000a0;Hz, 20&#x02013;25&#x000a0;V, 4&#x000a0;ms duration; MyoPacer, IonOptix Corporation, Milton, MA, USA). Cells were alternatively excited at 340 and 380&#x000a0;nm (hyper-switch dual excitation, IonOptix Corporation). The F340/F380 ratio was used as an index of cytosolic Ca<sup>2+</sup> concentration. In some experiments, caffeine or thapsigargin were washed in. For all Ca<sup>2+</sup> fluorescence experiments, cells were paced for 1&#x000a0;min at 1&#x000a0;Hz&#x000a0;before starting the measurements to ensure that Ca<sup>2+</sup> balance was at steady state.</p></sec><sec id="Sec8"><title>Protein extraction</title><p id="Par23">Isolated cardiomyocytes were incubated with DI for 24&#x000a0;h while myocytes isolated from the same heart were incubated for 24&#x000a0;h with vehicle and served as paired control. Myocytes were pelleted by centrifugation and dispensed in 1&#x000a0;ml TNE buffer. 40&#x000a0;&#x000b5;l protease inhibitor, 40&#x000a0;&#x000b5;l phosphatase inhibitor, 30&#x000a0;&#x000b5;l triton X-100 (10%), 5&#x000a0;&#x000b5;l PMSF (200&#x000a0;mM in 100% EtOH) and 20&#x000a0;&#x000b5;l sodium deoxycholate (12.5% in H<sub>2</sub>O) were added. Handled on ice at all times, samples were mechanically homogenized for 20&#x000a0;s, sonicated for 3&#x02009;&#x000d7;&#x02009;5&#x000a0;s and then centrifuged at 13,000&#x000a0;g and 4&#x000a0;&#x000b0;C for 10&#x000a0;min. The supernatant was used for further studies. To ensure equal protein loading, protein concentration was measured using the BCA Protein Assay Reagent Kit for microplate assay (Pierce, Rockford, USA). BSA in concentrations between 25 and 2000&#x000a0;&#x000b5;g/ml in TNE buffer was used as standard.</p></sec><sec id="Sec9"><title>Western blots</title><p id="Par24">Samples were prepared for electrophoresis by adding Roti-Load 1 (4&#x02009;&#x000d7;&#x02009;concentrated) (Carl Roth GmbH &#x00026; Co. KG, Karlsruhe, Germany) at 1:4 to respective identical amounts of protein. Samples were heated to 95&#x000a0;&#x000b0;C for 5&#x000a0;min and then loaded pairwise (DI and the corresponding control) into the wells of 8% or 12% SDS polyacrylamide gels, separated by electrophoresis and blotted to PVDF membranes, which were blocked in TBST solution containing 1% dry milk and probed for SERCA and phospholamban. Primary antibodies were: goat SERCA2 (C-20): sc-8094 (Santa Cruz Biotechnology, Santa Cruz, USA), mouse phospholamban: A010-14 (Badrilla Ltd., Leeds, United Kingdom), rabbit phospholamban pSer16: A010-12 (Badrilla Ltd.), rabbit phospholamban pThr17: A010-13 (Badrilla Ltd.). Secondary antibodies were: goat anti-rabbit (1:50,000, polyclonal, Santa Cruz), rabbit anti-goat (1:50,000, polyclonal, Sigma), goat anti-mouse (1:50,000, polyclonal, Santa Cruz). Blots were developed using the Super Signal West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific, Waltham, MA, USA). Chemiluminescence was acquired using a STELLA imager with the XStella and AIDA image analyzer software (raytest Isotopenme&#x000df;ger&#x000e4;te, Straubenhardt, Germany). Image saturation was prevented by adjusting exposure times of the camera. Using serial dilutions we ensured for each antibody that the applied amounts of protein were within the linear detection range of the imaging system. The amount of total protein was assessed using Ponceau S staining<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>.</p></sec><sec id="Sec10"><title>Solutions</title><p id="Par25">For the isolation of myocytes, modified Tyrode&#x02019;s solution contained (in mM): NaCl 138, KCl 4, Glucose 10, NaH<sub>2</sub>PO<sub>4</sub> 0.33, MgCl<sub>2</sub> 1, HEPES 10, CaCl<sub>2</sub> 4.5, EGTA 5, titrated to pH 7.30 using NaOH. The same solution&#x000a0;without EGTA and with 2&#x000a0;mM Ca<sup>2+</sup> was used as bath solution for the patch-clamp and fluorescence imaging experiments. For cell digestion, collagenase (162.8 U/ml, CLSII, Biochrom AG, Berlin, Deutschland) and protease (0.54 U/ml, type XIV, Sigma-Aldrich GmbH, Steinheim, Deutschland) were added to modified Tyrode&#x02019;s solution (10<sup>&#x02013;6</sup>&#x000a0;M Ca<sup>2+</sup>). Storage solution contained (in mM): NaCl 130, NaH<sub>2</sub>PO<sub>4</sub> 0.4, NaHCO<sub>3</sub> 5.8, MgCl<sub>2</sub> 0.5, CaCl<sub>2</sub> 1, KCl 5.4, glucose 22, and HEPES 25, titrated to pH 7.40 with NaOH in the presence of 5% CO<sub>2</sub> and supplemented with 1&#x000a0;mg&#x000a0;ml<sup>&#x02212;1</sup> BSA. For&#x000a0;recording action potentials and K<sup>+</sup>-currents, the pipette solution contained (in mM): glutamic acid 120, KCl 10, MgCl<sub>2</sub> 4, EGTA 10, HEPES 10, and Na<sub>2</sub>ATP 2, pH 7.20 with KOH. For recording Ca<sup>2+</sup> currents, the pipette solution contained (in mM): CsCl 130, MgCl<sub>2</sub> 5, EGTA 10, HEPES 10, Na<sub>2</sub>ATP 2, pH 7.20 with CsOH.</p><p id="Par26">For protein extraction and western blots, TNE buffer contained (in mM): Tris 20, NaCl 150, EDTA 1, pH&#x02009;=&#x02009;7.40 and was completed with protease inhibitor (Complete Mini, Roche, 1 tablet for 10&#x000a0;ml buffer) and PMSF (1&#x000a0;mM) just before starting protein extraction. SDS sample buffer was the mix from the homogenizing buffer and 4xRoti-Load (Roth, Karlsruhe, Germany). TBST solution contained (in mM): Tris 50, NaCl 150, 0.05% Tween-20, pH 7.6 with HCl.</p></sec><sec id="Sec11"><title>Data analysis and statistics</title><p id="Par27">Patch clamp data were analyzed using the PULSE-FIT software (HEKA Elektronik, Lambrecht/Pfalz, Germany), IGOR Pro (WaveMetrics, Lake Oswego, USA), and Microsoft Excel (Microsoft Corporation, Redmond, USA) as described previously<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Ca<sup>2+</sup> epifluorescence data were analyzed using Ionwizard 5.0 (IonOptix Corporation, Milton, USA) and Microsoft Excel. Quantitative densitometric analysis of western blots was performed using ImageJ software. The intensity of specific bands was determined after background subtraction and normalized to the total protein content per lane as quantified by densitometric analysis of the corresponding Ponceau stains<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>.</p><p id="Par28">Data are given as mean&#x02009;&#x000b1;&#x02009;SEM. Statistical significance was evaluated by paired or unpaired Student's <italic>t</italic> test when two groups were compared or one-way ANOVA followed by Newman-Keuls test (with the exception of APD<sub>0mV</sub> and Q<sub>Ca</sub>, which were analyzed by Kruskal Wallis test followed by Dunn's post test because both were not normally distributed) when more than two groups were compared using Prism 5 (GraphPad, San Diego, USA). <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec12"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2020_68308_MOESM1_ESM.pdf"><caption><p>Supplementary information 1</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Tilmann Volk and Michael Wagner.</p></fn></fn-group><sec><title>Supplementary information</title><p>is available for this paper at 10.1038/s41598-020-68308-4.</p></sec><ack><title>Acknowledgements</title><p>We gratefully acknowledge the expert technical assistance of C&#x000e9;line Gr&#x000fc;ninger and Lorenz McCargo. This work was supported by the Dr. Ernst und Anita Bauer-Stiftung and Otto Hess Promotionsstipendium der Deutschen Gesellschaft f&#x000fc;r Kardiologie&#x02014;Herz-Kreislaufforschung. The present work was performed in (partial) fulfillment of the requirements for obtaining the degree &#x0201e;Dr. med.&#x0201c;</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Conceptualization: TV and MW; Investigation: CW, ND, AS, AR and MW; Writing: CW, TV and MW.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par29">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandulik</surname><given-names>S</given-names></name></person-group><article-title>Of channels and pumps: different ways to boost the aldosterone?</article-title><source>Acta Physiol. (Oxf.)</source><year>2017</year><volume>220</volume><fpage>332</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">27862984</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitt</surname><given-names>B</given-names></name><etal/></person-group><article-title>The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators</article-title><source>N. Engl. J. Med.</source><year>1999</year><volume>341</volume><fpage>709</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">10471456</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitt</surname><given-names>B</given-names></name><etal/></person-group><article-title>Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction</article-title><source>N. Engl. J. Med.</source><year>2003</year><volume>348</volume><fpage>1309</fpage><lpage>1321</lpage><pub-id pub-id-type="pmid">12668699</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubart</surname><given-names>M</given-names></name><name><surname>Zipes</surname><given-names>DP</given-names></name></person-group><article-title>Mechanisms of sudden cardiac death</article-title><source>J. Clin. Invest.</source><year>2005</year><volume>115</volume><fpage>2305</fpage><lpage>2315</lpage><pub-id pub-id-type="pmid">16138184</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boixel</surname><given-names>C</given-names></name><name><surname>Gavillet</surname><given-names>B</given-names></name><name><surname>Rougier</surname><given-names>JS</given-names></name><name><surname>Abriel</surname><given-names>H</given-names></name></person-group><article-title>Aldosterone increases voltage-gated sodium current in ventricular myocytes</article-title><source>Am. J. Physiol. Heart Circ. Physiol.</source><year>2006</year><volume>290</volume><fpage>H2257</fpage><lpage>H2266</lpage><pub-id pub-id-type="pmid">16428353</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muto</surname><given-names>T</given-names></name><etal/></person-group><article-title>Aldosterone modulates I(f) current through gene expression in cultured neonatal rat ventricular myocytes</article-title><source>Am. J. Physiol. Heart Circ. Physiol.</source><year>2007</year><volume>293</volume><fpage>H2710</fpage><lpage>H2718</lpage><pub-id pub-id-type="pmid">17644563</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins</article-title><source>Circulation</source><year>2009</year><volume>119</volume><fpage>2179</fpage><lpage>2187</lpage><pub-id pub-id-type="pmid">19364981</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benitah</surname><given-names>JP</given-names></name><name><surname>Vassort</surname><given-names>G</given-names></name></person-group><article-title>Aldosterone upregulates Ca<sup>2+</sup> current in adult rat cardiomyocytes</article-title><source>Circ. Res.</source><year>1999</year><volume>85</volume><fpage>1139</fpage><lpage>1145</lpage><pub-id pub-id-type="pmid">10590240</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassiri</surname><given-names>Z</given-names></name><name><surname>Zobel</surname><given-names>C</given-names></name><name><surname>Nguyen</surname><given-names>TT</given-names></name><name><surname>Molkentin</surname><given-names>JD</given-names></name><name><surname>Backx</surname><given-names>PH</given-names></name></person-group><article-title>Reduction of I<sub>to</sub> causes hypertrophy in neonatal rat ventricular myocytes</article-title><source>Circ. Res.</source><year>2002</year><volume>90</volume><fpage>578</fpage><lpage>585</lpage><pub-id pub-id-type="pmid">11909822</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrier</surname><given-names>E</given-names></name><etal/></person-group><article-title>Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction</article-title><source>Circulation</source><year>2004</year><volume>110</volume><fpage>776</fpage><lpage>783</lpage><pub-id pub-id-type="pmid">15289366</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouvrard-Pascaud</surname><given-names>A</given-names></name><etal/></person-group><article-title>Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias</article-title><source>Circulation</source><year>2005</year><volume>111</volume><fpage>3025</fpage><lpage>3033</lpage><pub-id pub-id-type="pmid">15939817</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antzelevitch</surname><given-names>C</given-names></name><name><surname>Fish</surname><given-names>J</given-names></name></person-group><article-title>Electrical heterogeneity within the ventricular wall</article-title><source>Basic Res. Cardiol.</source><year>2001</year><volume>96</volume><fpage>517</fpage><lpage>527</lpage><pub-id pub-id-type="pmid">11770069</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nerbonne</surname><given-names>JM</given-names></name><name><surname>Kass</surname><given-names>RS</given-names></name></person-group><article-title>Molecular physiology of cardiac repolarization</article-title><source>Physiol. Rev.</source><year>2005</year><volume>85</volume><fpage>1205</fpage><lpage>1253</lpage><pub-id pub-id-type="pmid">16183911</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosati</surname><given-names>B</given-names></name><name><surname>Grau</surname><given-names>F</given-names></name><name><surname>McKinnon</surname><given-names>D</given-names></name></person-group><article-title>Regional variation in mRNA transcript abundance within the ventricular wall</article-title><source>J. Mol. Cell Cardiol.</source><year>2006</year><volume>40</volume><fpage>295</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">16412459</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volk</surname><given-names>T</given-names></name><name><surname>Nguyen</surname><given-names>THD</given-names></name><name><surname>Schultz</surname><given-names>JH</given-names></name><name><surname>Faulhaber</surname><given-names>J</given-names></name><name><surname>Ehmke</surname><given-names>H</given-names></name></person-group><article-title>Regional alterations of repolarizing K<sup>+</sup> currents among the left ventricular wall of rats with ascending aortic stenosis</article-title><source>J. Physiol.</source><year>2001</year><volume>530</volume><fpage>443</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">11158275</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>RB</given-names></name><name><surname>Bouchard</surname><given-names>RA</given-names></name><name><surname>Salinas</surname><given-names>SE</given-names></name><name><surname>Sanchez-Chapula</surname><given-names>JA</given-names></name><name><surname>Giles</surname><given-names>WR</given-names></name></person-group><article-title>Heterogeneity of action potential waveforms and potassium currents in rat ventricle</article-title><source>Cardiovasc. Res.</source><year>1993</year><volume>27</volume><fpage>1795</fpage><lpage>1799</lpage><pub-id pub-id-type="pmid">8275526</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>N&#x000e4;bauer</surname><given-names>M</given-names></name><name><surname>Beuckelmann</surname><given-names>DJ</given-names></name><name><surname>&#x000dc;berfuhr</surname><given-names>P</given-names></name><name><surname>Steinbeck</surname><given-names>G</given-names></name></person-group><article-title>Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle</article-title><source>Circulation</source><year>1996</year><volume>93</volume><fpage>168</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">8616924</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>PJ</given-names></name><name><surname>Soeller</surname><given-names>C</given-names></name><name><surname>Cannell</surname><given-names>MB</given-names></name></person-group><article-title>Excitation&#x02013;contraction coupling in human heart failure examined by action potential clamp in rat cardiac myocytes</article-title><source>J. Mol. Cell Cardiol.</source><year>2010</year><volume>49</volume><fpage>911</fpage><lpage>917</lpage><pub-id pub-id-type="pmid">20430038</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priebe</surname><given-names>L</given-names></name><name><surname>Beuckelmann</surname><given-names>DJ</given-names></name></person-group><article-title>Simulation study of cellular electric properties in heart failure</article-title><source>Circ. Res.</source><year>1998</year><volume>82</volume><fpage>1206</fpage><lpage>1223</lpage><pub-id pub-id-type="pmid">9633920</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volk</surname><given-names>T</given-names></name><name><surname>Nguyen</surname><given-names>THD</given-names></name><name><surname>Schultz</surname><given-names>JH</given-names></name><name><surname>Ehmke</surname><given-names>H</given-names></name></person-group><article-title>Relationship between transient outward K<sup>+</sup> current and Ca<sup>2+</sup> influx in rat cardiac myocytes of endo- and epicardial origin</article-title><source>J. Physiol.</source><year>1999</year><volume>519</volume><fpage>841</fpage><lpage>850</lpage><pub-id pub-id-type="pmid">10457095</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Alarcon</surname><given-names>MM</given-names></name><name><surname>de Rodriguez</surname><given-names>YA</given-names></name><name><surname>Felice</surname><given-names>JI</given-names></name><name><surname>Medei</surname><given-names>E</given-names></name><name><surname>Escobar</surname><given-names>AL</given-names></name></person-group><article-title>Phase 1 repolarization rate defines Ca(<sup>2+</sup>) dynamics and contractility on intact mouse hearts</article-title><source>J. Gen. Physiol</source><year>2019</year><volume>151</volume><fpage>771</fpage><lpage>785</lpage><pub-id pub-id-type="pmid">31000581</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sah</surname><given-names>R</given-names></name><etal/></person-group><article-title>Inhibition of calcineurin and sarcolemmal Ca<sup>2+</sup> influx protects cardiac morphology and ventricular function in Kv4.2N transgenic mice</article-title><source>Circulation</source><year>2002</year><volume>105</volume><fpage>1850</fpage><lpage>1856</lpage><pub-id pub-id-type="pmid">11956130</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><etal/></person-group><article-title>Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy</article-title><source>J. Mol. Cell Cardiol.</source><year>2010</year><volume>50</volume><fpage>460</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">21111744</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>M</given-names></name><etal/></person-group><article-title>Role of the transient outward current in regulating mechanical properties of canine ventricular myocytes</article-title><source>J. Cardiovasc. Electrophysiol.</source><year>2010</year><volume>21</volume><fpage>697</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">20132386</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Alterations in early action potential repolarization causes localized failure of sarcoplasmic reticulum Ca<sup>2+</sup> release</article-title><source>Circ. Res.</source><year>2005</year><volume>96</volume><fpage>543</fpage><lpage>550</lpage><pub-id pub-id-type="pmid">15705962</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000f3;mez</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Modulation of electrical heterogeneity by compensated hypertrophy in rat left ventricle</article-title><source>Am. J. Physiol.</source><year>1997</year><volume>272</volume><fpage>H1078</fpage><lpage>H1086</lpage><pub-id pub-id-type="pmid">9087578</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Rudakova</surname><given-names>E</given-names></name><name><surname>Volk</surname><given-names>T</given-names></name></person-group><article-title>Aldosterone-induced changes in the cardiac L-type Ca<sup>2+</sup> current can be prevented by antioxidants in vitro and are absent in rats on low salt diet</article-title><source>Pflugers Arch.</source><year>2008</year><volume>457</volume><fpage>339</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">18504604</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rousseau</surname><given-names>E</given-names></name><name><surname>Meissner</surname><given-names>G</given-names></name></person-group><article-title>Single cardiac sarcoplasmic reticulum Ca<sup>2+</sup>-release channel: activation by caffeine</article-title><source>Am. J. Physiol.</source><year>1989</year><volume>256</volume><fpage>H328</fpage><lpage>H333</lpage><pub-id pub-id-type="pmid">2537030</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volk</surname><given-names>T</given-names></name><name><surname>Ehmke</surname><given-names>H</given-names></name></person-group><article-title>Conservation of L-type Ca<sup>2+</sup> current characteristics in endo- and epicardial myocytes from rat left ventricle with pressure-induced hypertrophy</article-title><source>Pflugers Arch.</source><year>2002</year><volume>443</volume><fpage>399</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">11810209</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouchard</surname><given-names>RA</given-names></name><name><surname>Clark</surname><given-names>RB</given-names></name><name><surname>Giles</surname><given-names>WR</given-names></name></person-group><article-title>Effects of action potential duration on excitation&#x02013;contraction coupling in rat ventricular myocytes. Action potential voltage-clamp measurements</article-title><source>Circ. Res.</source><year>1995</year><volume>76</volume><fpage>790</fpage><lpage>801</lpage><pub-id pub-id-type="pmid">7728996</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>ZK</given-names></name><etal/></person-group><article-title>Regional differences in the negative inotropic effect of acetylcholine within the canine ventricle</article-title><source>J. Physiol.</source><year>1996</year><volume>492</volume><issue>Pt 3</issue><fpage>789</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">8734990</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordeiro</surname><given-names>JM</given-names></name><name><surname>Greene</surname><given-names>L</given-names></name><name><surname>Heilmann</surname><given-names>C</given-names></name><name><surname>Antzelevitch</surname><given-names>D</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name></person-group><article-title>Transmural heterogeneity of calcium activity and mechanical function in the canine left ventricle</article-title><source>Am. J. Physiol. Heart Circ. Physiol.</source><year>2004</year><volume>286</volume><fpage>H1471</fpage><lpage>H1479</lpage><pub-id pub-id-type="pmid">14670817</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamunorwa</surname><given-names>JP</given-names></name><name><surname>O'Neill</surname><given-names>SC</given-names></name></person-group><article-title>Regional differences in rest decay and recoveries of contraction and the calcium transient in rabbit ventricular muscle</article-title><source>Pflugers Arch.</source><year>1995</year><volume>430</volume><fpage>195</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">7675629</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dilly</surname><given-names>KW</given-names></name><etal/></person-group><article-title>Mechanisms underlying variations in excitation&#x02013;contraction coupling across the mouse left ventricular free wall</article-title><source>J. Physiol</source><year>2006</year><volume>572</volume><fpage>227</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">16423856</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fowler</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Decreased Ca<sup>2+</sup> extrusion via Na<sup>+</sup>/Ca<sup>2+</sup> exchange in epicardial left ventricular myocytes during compensated hypertrophy</article-title><source>Am. J. Physiol Heart Circ. Physiol</source><year>2005</year><volume>288</volume><fpage>H2431</fpage><lpage>H2438</lpage><pub-id pub-id-type="pmid">15615841</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cazorla</surname><given-names>O</given-names></name><name><surname>Le Guennec</surname><given-names>JY</given-names></name><name><surname>White</surname><given-names>E</given-names></name></person-group><article-title>Length-tension relationships of sub-epicardial and sub-endocardial single ventricular myocytes from rat and ferret hearts</article-title><source>J. Mol. Cell Cardiol.</source><year>2000</year><volume>32</volume><fpage>735</fpage><lpage>744</lpage><pub-id pub-id-type="pmid">10775479</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smail</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Regional effects of streptozotocin-induced diabetes on shortening and calcium transport in epicardial and endocardial myocytes from rat left ventricle</article-title><source>Physiol. Rep.</source><year>2016</year><volume>4</volume><fpage>13024</fpage></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisner</surname><given-names>DA</given-names></name><name><surname>Caldwell</surname><given-names>JL</given-names></name><name><surname>Kistamas</surname><given-names>K</given-names></name><name><surname>Trafford</surname><given-names>AW</given-names></name></person-group><article-title>Calcium and excitation&#x02013;contraction coupling in the heart</article-title><source>Circ. Res.</source><year>2017</year><volume>121</volume><fpage>181</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">28684623</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sham</surname><given-names>JS</given-names></name></person-group><article-title>Ca<sup>2+</sup> release-induced inactivation of Ca<sup>2+</sup> current in rat ventricular myocytes: evidence for local Ca<sup>2+</sup> signalling</article-title><source>J. Physiol.</source><year>1997</year><volume>500</volume><fpage>285</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">9147317</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrier</surname><given-names>R</given-names></name><etal/></person-group><article-title>A direct relationship between plasma aldosterone and cardiac L-type Ca<sup>2+</sup> current</article-title><source>J Physiol</source><year>2005</year><volume>569</volume><fpage>153</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">16166161</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sah</surname><given-names>R</given-names></name><name><surname>Ramirez</surname><given-names>RJ</given-names></name><name><surname>Kaprielian</surname><given-names>R</given-names></name><name><surname>Backx</surname><given-names>PH</given-names></name></person-group><article-title>Alterations in action potential profile enhance excitation&#x02013;contraction coupling in rat cardiac myocytes</article-title><source>J. Physiol.</source><year>2001</year><volume>533</volume><fpage>201</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">11351028</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassani</surname><given-names>JW</given-names></name><name><surname>Yuan</surname><given-names>W</given-names></name><name><surname>Bers</surname><given-names>DM</given-names></name></person-group><article-title>Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes</article-title><source>Am. J. Physiol.</source><year>1995</year><volume>268</volume><fpage>C1313</fpage><lpage>C1319</lpage><pub-id pub-id-type="pmid">7762626</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trafford</surname><given-names>AW</given-names></name><name><surname>Diaz</surname><given-names>ME</given-names></name><name><surname>Sibbring</surname><given-names>GC</given-names></name><name><surname>Eisner</surname><given-names>DA</given-names></name></person-group><article-title>Modulation of CICR has no maintained effect on systolic Ca<sup>2+</sup>: simultaneous measurements of sarcoplasmic reticulum and sarcolemmal Ca<sup>2+</sup> fluxes in rat ventricular myocytes</article-title><source>J. Physiol.</source><year>2000</year><volume>522</volume><fpage>259</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">10639102</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trafford</surname><given-names>AW</given-names></name><name><surname>Diaz</surname><given-names>ME</given-names></name><name><surname>Eisner</surname><given-names>DA</given-names></name></person-group><article-title>Coordinated control of cell Ca<sup>2+</sup> loading and triggered release from the sarcoplasmic reticulum underlies the rapid inotropic response to increased L-type Ca<sup>2+</sup> current</article-title><source>Circ. Res.</source><year>2001</year><volume>88</volume><fpage>195</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">11157672</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaprielian</surname><given-names>R</given-names></name><name><surname>Sah</surname><given-names>R</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Wickenden</surname><given-names>AD</given-names></name><name><surname>Backx</surname><given-names>PH</given-names></name></person-group><article-title>Myocardial infarction in rat eliminates regional heterogeneity of AP profiles, Ito K<sup>+</sup> currents, and [Ca<sup>2+</sup>]<sub>i</sub> transients</article-title><source>Am. J. Physiol.</source><year>2002</year><volume>283</volume><fpage>H1157</fpage><lpage>H1168</lpage></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picht</surname><given-names>E</given-names></name><etal/></person-group><article-title>Dynamic calcium movement inside cardiac sarcoplasmic reticulum during release</article-title><source>Circ. Res.</source><year>2011</year><volume>108</volume><fpage>847</fpage><lpage>856</lpage><pub-id pub-id-type="pmid">21311044</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>EF</given-names></name><etal/></person-group><article-title>Changes of SERCA activity have only modest effects on sarcoplasmic reticulum Ca<sup>2+</sup> content in rat ventricular myocytes</article-title><source>J. Physiol.</source><year>2011</year><volume>589</volume><fpage>4723</fpage><lpage>4729</lpage><pub-id pub-id-type="pmid">21825024</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kho</surname><given-names>C</given-names></name><etal/></person-group><article-title>SUMO1-dependent modulation of SERCA2a in heart failure</article-title><source>Nature</source><year>2011</year><volume>477</volume><fpage>601</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">21900893</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCrink</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Beta-Arrestin2 improves post-myocardial infarction heart failure via Sarco(endo)plasmic reticulum Ca(<sup>2+</sup>)-ATPase-dependent positive inotropy in cardiomyocytes</article-title><source>Hypertension</source><year>2017</year><volume>70</volume><fpage>972</fpage><lpage>981</lpage><pub-id pub-id-type="pmid">28874462</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oakley</surname><given-names>RH</given-names></name><name><surname>Revollo</surname><given-names>J</given-names></name><name><surname>Cidlowski</surname><given-names>JA</given-names></name></person-group><article-title>Glucocorticoids regulate arrestin gene expression and redirect the signaling profile of G protein-coupled receptors</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2012</year><volume>109</volume><fpage>17591</fpage><lpage>17596</lpage><pub-id pub-id-type="pmid">23045642</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>M</given-names></name><etal/></person-group><article-title>Lipid rescue reverses the bupivacaine-induced block of the fast Na<sup>+</sup> Current (INa) in cardiomyocytes of the rat left ventricle</article-title><source>Anesthesiology</source><year>2013</year><volume>476</volume><fpage>22</fpage></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamill</surname><given-names>OP</given-names></name><name><surname>Marty</surname><given-names>A</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name><name><surname>Sakmann</surname><given-names>B</given-names></name><name><surname>Sigworth</surname><given-names>FJ</given-names></name></person-group><article-title>Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches</article-title><source>Pflugers Arch.</source><year>1981</year><volume>391</volume><fpage>85</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">6270629</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doerr</surname><given-names>T</given-names></name><name><surname>Denger</surname><given-names>R</given-names></name><name><surname>Trautwein</surname><given-names>W</given-names></name></person-group><article-title>Calcium currents in single SA nodal cells of the rabbit heart studied with action potential clamp</article-title><source>Pflugers Arch.</source><year>1989</year><volume>413</volume><fpage>599</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">2726423</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foltz</surname><given-names>WU</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Rudakova</surname><given-names>E</given-names></name><name><surname>Volk</surname><given-names>T</given-names></name></person-group><article-title>N-Acetylcysteine prevents electrical remodeling and attenuates cellular hypertrophy in epicardial myocytes of rats with ascending aortic stenosis</article-title><source>Basic Res. Cardiol.</source><year>2012</year><volume>107</volume><fpage>290</fpage><pub-id pub-id-type="pmid">22855324</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pohlmann</surname><given-names>L</given-names></name><etal/></person-group><article-title>Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes</article-title><source>Circ. Res.</source><year>2007</year><volume>101</volume><fpage>928</fpage><lpage>938</lpage><pub-id pub-id-type="pmid">17823372</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwoerer</surname><given-names>AP</given-names></name><etal/></person-group><article-title>Enhanced Ca influx through cardiac L-type Ca channels maintains the systolic Ca transient in early cardiac atrophy induced by mechanical unloading</article-title><source>Pflugers Arch.</source><year>2013</year><volume>465</volume><fpage>1763</fpage><lpage>1773</lpage><pub-id pub-id-type="pmid">23842739</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonough</surname><given-names>AA</given-names></name><name><surname>Veiras</surname><given-names>LC</given-names></name><name><surname>Minas</surname><given-names>JN</given-names></name><name><surname>Ralph</surname><given-names>DL</given-names></name></person-group><article-title>Considerations when quantitating protein abundance by immunoblot</article-title><source>Am. J. Physiol. Cell Physiol.</source><year>2015</year><volume>308</volume><fpage>C426</fpage><lpage>C433</lpage><pub-id pub-id-type="pmid">25540176</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>SC</given-names></name><name><surname>Posch</surname><given-names>A</given-names></name></person-group><article-title>The design of a quantitative western blot experiment</article-title><source>Biomed. Res. Int.</source><year>2014</year><volume>2014</volume><fpage>361590</fpage><pub-id pub-id-type="pmid">24738055</pub-id></element-citation></ref></ref-list></back></article>